Judge, D. P., Alexander, K. M., Cappelli, F., Fontana, M., Garcia-Pavia, P., Gibbs, S. D. J., Grogan, M., Hanna, M., Masri, A., Maurer, M. S., Obici, L., Soman, P., Cao, X., Lystig, T., Tamby, J.-F., Siddhanti, S., Castaño, A., Katz, L., Fox, J. C., … Gillmore, J. D. (2025). Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology, 85(10), 1003–1014. https://doi.org/10.1016/j.jacc.2024.11.042

Gonzalez-Lopez, E., Maurer, M. S., & Garcia-Pavia, P. (2025). Transthyretin amyloid cardiomyopathy: a paradigm for advancing precision medicine. European Heart Journal. https://doi.org/10.1093/eurheartj/ehae811

Fontana, M., Maurer, M. S., Gillmore, J. D., Bender, S., Jay, P. Y., & Solomon, S. D. (2025). Worsening of Heart Failure in Outpatients With Transthyretin Amyloidosis and Cardiomyopathy in the APOLLO-B Trial. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2024.10.097

Fontana, M., Maurer, M. S., Gillmore, J. D., Bender, S., Aldinc, E., Eraly, S. A., Jay, P. Y., & Solomon, S. D. (2024). Outpatient Worsening Heart Failure in Patients with Transthyretin Amyloidosis with Cardiomyopathy in the HELIOS-B Trial. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2024.11.015

Wu, W., Jin, Q., Östlund, C., Tanji, K., Shin, J.-Y., Han, J., Leu, C.-S., Kushner, J., & Worman, H. J. (2024). mTOR Inhibition Prolongs Survival and Has Beneficial Effects on Heart Function After Onset of Lamin A/C Gene Mutation Cardiomyopathy in Mice. Circulation: Heart Failure, 17(4). https://doi.org/10.1161/circheartfailure.123.011110

Ruberg, F. L., & Maurer, M. S. (2024). Cardiac Amyloidosis Due to Transthyretin Protein. JAMA, 331(9), 778. https://doi.org/10.1001/jama.2024.0442

Kantor, P. F., Shi, L., Colan, S. D., Orav, E. J., Wilkinson, J. D., Hamza, T. H., Webber, S. A., Canter, C. E., Towbin, J. A., Everitt, M. D., Pahl, E., Ware, S. M., Rusconi, P. G., Lamour, J. M., Jefferies, J. L., Addonizio, L. J., & Lipshultz, S. E. (2024). Progressive Left Ventricular Remodeling for Predicting Mortality in Children With Dilated Cardiomyopathy: The Pediatric Cardiomyopathy Registry. Journal of the American Heart Association, 13(2). https://doi.org/10.1161/jaha.121.022557

Souidi, M., Resta, J., Dridi, H., Sleiman, Y., Reiken, S., Formoso, K., Colombani, S., Amédro, P., Meyer, P., Charrabi, A., Vincenti, M., Liu, Y., Soni, R. K., Lezoualc’h, F., Stéphane Blot, D. V. M., Rivier, F., Cazorla, O., Parini, A., Marks, A. R., … Meli, A. C. (2024). Ryanodine receptor dysfunction causes senescence and fibrosis in Duchenne dilated cardiomyopathy. Journal of Cachexia, Sarcopenia and Muscle, 15(2), 536–551. Portico. https://doi.org/10.1002/jcsm.13411

Shah, S. J., Fine, N., Garcia-Pavia, P., Klein, A. L., Fernandes, F., Weissman, N. J., Maurer, M. S., Boman, K., Gundapaneni, B., Sultan, M. B., & Elliott, P. (2024). Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy. JAMA Cardiology, 9(1), 25. https://doi.org/10.1001/jamacardio.2023.4147

Miller, P., Maurer, M. S., Einstein, A. J., Elias, P., & Poterucha, T. J. (2023). Recognizing Cardiac Amyloidosis Phenotype by Echocardiography Increases Downstream Testing. Journal of the American Society of Echocardiography, 36(12), 1326–1329. https://doi.org/10.1016/j.echo.2023.08.018

Chan, N., Einstein, A. J., Griffin, J. M., Rosenblum, H., Teruya, S., Cuomo, M., De Los Santos, J., DeLuca, A., Johnson, L. L., Kinkhabwala, M. P., Leb, J. S., Mintz, A., Fine, D., Helmke, S., Muralidhar, V., Pandey, S., Sabogal, N., Saith, S. E., Winburn, M., … Maurer, M. S. (2023). Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases. Journal of Nuclear Cardiology, 30(6), 2531–2539. https://doi.org/10.1007/s12350-023-03310-7

Azad, H., Wen, T., Bello, N. A., Booker, W. A., Purisch, S., D’Alton, M. E., & Friedman, A. M. (2023). Peripartum cardiomyopathy delivery hospitalization and postpartum readmission trends, risk factors, and outcomes. Pregnancy Hypertension, 34, 116–123. https://doi.org/10.1016/j.preghy.2023.11.004

Maurer, M. S., Kale, P., Fontana, M., Berk, J. L., Grogan, M., Gustafsson, F., Hung, R. R., Gottlieb, R. L., Damy, T., González-Duarte, A., Sarswat, N., Sekijima, Y., Tahara, N., Taylor, M. S., Kubanek, M., Donal, E., Palecek, T., Tsujita, K., Tang, W. H. W., … Gillmore, J. D. (2023). Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis. New England Journal of Medicine, 389(17), 1553–1565. https://doi.org/10.1056/nejmoa2300757

Richmond, M. E., Conway, J., Kirklin, J. K., Cantor, R. S., Koehl, D. A., Lal, A. K., McDonald, N., Gajarski, R., Lin, K. Y., Singh, R. K., Fenton, M., Asante‐Korang, A., Amdani, S., Auerbach, S. R., & Everitt, M. D. (2023). Three decades of collaboration through the Pediatric Heart Transplant Society Registry: A journey through registry data with a highlight on children with single ventricle anatomy. Pediatric Transplantation, 28(1). Portico. https://doi.org/10.1111/petr.14615

Guerrero, M. E., Eleid, M. F., Wang, D. D., Pursnani, A., Kodali, S. K., George, I., Palacios, I., Russell, H., Makkar, R. R., Kar, S., Satler, L. F., Rajagopal, V., Dangas, G., Tang, G. H. L., McCabe, J. M., Whisenant, B. K., Fang, K., Balan, P., Smalling, R., … Rihal, C. (2023). 5-Year Prospective Evaluation of Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-MAC Outcomes. JACC: Cardiovascular Interventions, 16(18), 2211–2227. https://doi.org/10.1016/j.jcin.2023.06.041

Smiley, D. A., Einstein, A. J., Mintz, A., Shetty, M., Chan, N., Helmke, S. T., Bhatia, K., Goldner, K., Brannagan, T. H., Santana, D. D., & Maurer, M. S. (2023). Gene Silencing Therapy in Hereditary (Variant) Transthyretin Cardiac Amyloidosis: A Puzzling Case of Decreasing Pyrophosphate Uptake on Scintigraphy. Circulation: Cardiovascular Imaging, 16(8). https://doi.org/10.1161/circimaging.123.015243

DUVALL, C., PAVLOVIC, N., ROSEN, N. S., WAND, A. L., GRIFFIN, J. M., OKADA, D. R., TANDRI, H., KASPER, E. K., SHARP, M., CHEN, E. S., CHRISPIN, J., & GILOTRA, N. A. (2023). Sex and Race Differences in Cardiac Sarcoidosis Presentation, Treatment and Outcomes. Journal of Cardiac Failure, 29(8), 1135–1145. https://doi.org/10.1016/j.cardfail.2023.03.022

Madhani, A., Sabogal, N., Massillon, D., Paul, L. D., Rodriguez, C., Fine, D., Helmke, S., Winburn, M., Kurian, D., Raiszadeh, F., Teruya, S., Cohn, E., Einstein, A. J., Miller, E. J., Connors, L. H., Maurer, M. S., & Ruberg, F. L. (2023). Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN‐MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study. Journal of the American Heart Association, 12(15). https://doi.org/10.1161/jaha.122.028973

Pandey, S., Teruya, S., Rodriguez, C., Deluca, A., Kinkhabwala, M., Johnson, L. L., Fine, D., Sabogal, N., Winburn, M., Castillo, M., Bhatia, K., Malkovskaya, R., Raiszadeh, F., Kurian, D., Miller, E. J., Einstein, A. J., Maurer, M. S., & Ruberg, F. L. (2023). Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc99m pyrophosphate (PYP) imaging for diagnosis of transthyretin (ATTR) cardiac amyloidosis: the SCAN-MP study. Journal of Nuclear Cardiology, 30(4), 1414–1419. https://doi.org/10.1007/s12350-023-03203-9

Hamid, N., JORDE, U. P., REISMAN, M., LATIB, A., LIM, D. S., JOSEPH, S. M., KURLIANSKAYA, A., POLONETSKY, O., NEUZIL, P., REDDY, V., FOERST, J., GADA, H., GRUBB, K. J., SILVA, G., KEREIAKES, D., SHREENIVAS, S., PINNEY, S., DAVIDAVICIUS, G., SORAJJA, P., … BURKHOFF, D. (2023). Transcatheter Left Ventricular Restoration in Patients With Heart Failure. Journal of Cardiac Failure, 29(7), 1046–1055. https://doi.org/10.1016/j.cardfail.2023.03.003

Smiley, D., Einstein, A. J., Chan, N., Mintz, A., Santana, D. D., Shetty, M., Sekulic, M., Goldner, K., Wall, J., Helmke, S., & Maurer, M. S. (2023). In the thick of it: hereditary cardiac amyloidosis identified by 124I-AT-01 PET imaging but not cardiac MRI or SPECT 99mTc pyrophosphate scintigraphy. Journal of Nuclear Cardiology, 30(3), 1258–1262. https://doi.org/10.1007/s12350-023-03267-7

Wright, L. K., Gajarski, R. J., Phelps, C., Hoffman, T. M., Lytrivi, I. D., Magnetta, D. A., Shaw, F. R., Thompson, C., Weisert, M., & Nandi, D. (2022). Worsening racial disparity in waitlist mortality for pediatric heart transplant candidates since the 2016 Pediatric Heart Allocation Policy revision. Pediatric Transplantation, 27(3). Portico. https://doi.org/10.1111/petr.14412

Abrams, M., Magun, E., & DeFilippis, E. M. (2023). Considerations for specific cardiomyopathies during pregnancy. Current Opinion in Cardiology, 38(3), 233–240. https://doi.org/10.1097/hco.0000000000001033

Ruberg, F. L., Blaner, W. S., Chiuzan, C., Connors, L. H., Einstein, A. J., Fine, D., Helmke, S., Kurian, D., Pandey, S., Raiszadeh, F., Rodriguez, C., Sabogal, N., Teruya, S., Winburn, M., Chung, W. K., Cohn, E., Miller, E. J., Kelly, J. W., & Maurer, M. S. (2023). Design and Rationale the SCAN‐MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study. Journal of the American Heart Association, 12(8). https://doi.org/10.1161/jaha.122.028534

Basdavanos, A., Maurer, M. S., Ives, L., Derwin, K., Ricchetti, E. T., Seitz, W., & Hanna, M. (2023). Prevalence of Orthopedic Manifestations in Patients With Cardiac Amyloidosis With a Focus on Shoulder Pathologies. The American Journal of Cardiology, 190, 67–74. https://doi.org/10.1016/j.amjcard.2022.11.014

DiLorenzo, M. P., Farooqi, K. M., Shah, A. M., Channing, A., Harrington, J. K., Connors, T. J., Martirosyan, K., Krishnan, U. S., Ferris, A., Weller, R. J., Farber, D. L., Milner, J. D., Gorelik, M., Rosenzweig, E. B., & Anderson, B. R. (2022). Ventricular function and tissue characterization by cardiac magnetic resonance imaging following hospitalization for multisystem inflammatory syndrome in children: a prospective study. Pediatric Radiology, 53(3), 394–403. https://doi.org/10.1007/s00247-022-05521-5

Lotan, D., DeFilippis, E. M., Oren, D., Vinogradsky, A., Rubinstein, G., Mathur, A., Takeda, K., Hua, M., Gaglio, P. J., Szabolcs, M. J., Sayer, G., Uriel, N., Iglesias, A. D., & Latif, F. (2023). Combined heart and liver transplantation in a patient supported by left ventricular assist device (LVAD) with propionic acidemia. Nutrition, Metabolism and Cardiovascular Diseases, 33(3), 667–670. https://doi.org/10.1016/j.numecd.2022.12.022

Liao, X., Kennel, P. J., Liu, B., Nash, T. R., Zhuang, R. Z., Godier-Furnemont, A. F., Xue, C., Lu, R., Colombo, P. C., Uriel, N., Reilly, M. P., Marx, S. O., Vunjak-Novakovic, G., & Topkara, V. K. (2023). Effect of mechanical unloading on genome-wide DNA methylation profile of the failing human heart. JCI Insight, 8(4). https://doi.org/10.1172/jci.insight.161788

Tompkins, C. M., Zareba, W., Greenberg, H., Goldstein, R., McNitt, S., Polonsky, B., Brown, M., & Kutyifa, V. (2023). Differences in mode of death between men and women receiving implantable cardioverter-defibrillators or cardiac resynchronization therapy in the MADIT trials. Heart Rhythm, 20(1), 39–45. https://doi.org/10.1016/j.hrthm.2022.08.018

Maurer, M. S. (2022). Overview of Current and Emerging Therapies for Amyloid Transthyretin Cardiomyopathy. The American Journal of Cardiology, 185, S23–S34. https://doi.org/10.1016/j.amjcard.2022.10.014

Maurer, M. S., Smiley, D., Simsolo, E., Remotti, F., Bustamante, A., Teruya, S., Helmke, S., Einstein, A. J., Lehman, R., Giles, J. T., Kelly, J. W., Tsai, F., Blaner, W. S., Brun, P., Riesenburger, R. I., Kryzanski, J., Varga, C., & Patel, A. R. (2022). Analysis of lumbar spine stenosis specimens for identification of amyloid. Journal of the American Geriatrics Society, 70(12), 3538–3548. Portico. https://doi.org/10.1111/jgs.17976

Huded, C. P., Arnold, S. V., Chhatriwalla, A. K., Saxon, J. T., Kapadia, S., Yu, X., Webb, J. G., Thourani, V. H., Kodali, S. K., Smith, C. R., Mack, M. J., Leon, M. B., & Cohen, D. J. (2022). Rehospitalization Events After Aortic Valve Replacement: Insights From the PARTNER Trial. Circulation: Cardiovascular Interventions, 15(12). https://doi.org/10.1161/circinterventions.122.012195

Smiley, D. A., Rodriguez, C. M., & Maurer, M. S. (2022). Transthyretin Cardiac Amyloidosis. Cardiology Clinics, 40(4), 541–558. https://doi.org/10.1016/j.ccl.2022.06.008

Cuddy, S. A., Datar, Y., Ovsak, G., Saith, S., Murphy, S. P., Bay, C. P., Haddad, M., Lilleness, B., Muralidhar, V., Pipilas, A., Vuong, J., Guardino, E., Maurer, M. S., Ruberg, F. L., Falk, R. H., & Dorbala, S. (2022). Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis. Circulation: Cardiovascular Imaging, 15(11). https://doi.org/10.1161/circimaging.122.014645

Miller, E. J., Campisi, R., Shah, N. R., McMahon, S., Cuddy, S., Gallegos-Kattan, C., Maurer, M. S., Damy, T., Slart, R. H. J. A., Bhatia, K., & Einstein, A. J. (2022). Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement. Journal of Nuclear Cardiology, 29(5), 2748–2760. https://doi.org/10.1007/s12350-022-03059-5

Marques, M. D., Weinberg, R., Kapoor, S., Ostovaneh, M. R., Kato, Y., Liu, C. Y., Shea, S., McClelland, R. L., Post, W. S., Bluemke, D. A., Lima, J. A. C., & Ambale-Venkatesh, B. (2022). Myocardial fibrosis by T1 mapping magnetic resonance imaging predicts incident cardiovascular events and all-cause mortality: the Multi-Ethnic Study of Atherosclerosis. European Heart Journal - Cardiovascular Imaging, 23(10), 1407–1416. https://doi.org/10.1093/ehjci/jeac010

Poterucha, T. J., Kurian, D., Raiszadeh, F., Teruya, S., Elias, P., Kogan, R., Chiuzan, C., Einstein, A. J., Ruberg, F. L., & Maurer, M. S. (2022). Relation of Body Mass Index to Transthyretin Cardiac Amyloidosis Particularly in Black and Hispanic Patients (from the SCAN-MP Study). The American Journal of Cardiology, 177, 116–120. https://doi.org/10.1016/j.amjcard.2022.05.003

Lin, H., Zhang, X., Einstein, A. J., & Tang, G. (2022). Serial Tc-99m MDP scintigraphy demonstrating increasing cardiac uptake over time in a patient with light-chain cardiac amyloidosis. Journal of Nuclear Cardiology, 29(4), 2024–2028. https://doi.org/10.1007/s12350-022-02987-6

Vilches, S., Fontana, M., Gonzalez‐Lopez, E., Mitrani, L., Saturi, G., Renju, M., Griffin, J. M., Caponetti, A., Gnanasampanthan, S., De los Santos, J., Gagliardi, C., Rivas, A., Dominguez, F., Longhi, S., Rapezzi, C., Maurer, M. S., Gillmore, J., & Garcia‐Pavia, P. (2022). Systemic embolism in amyloid transthyretin cardiomyopathy. European Journal of Heart Failure, 24(8), 1387–1396. Portico. https://doi.org/10.1002/ejhf.2566

DiLorenzo, M. P., DeCost, G., Mai, A. D., Hughes, N., Goldmuntz, E., Jones, A., Fogel, M. A., & Mercer-Rosa, L. (2022). Comparison of serum biomarkers of myocardial fibrosis with cardiac magnetic resonance in patients operated for tetralogy of Fallot. International Journal of Cardiology, 358, 27–33. https://doi.org/10.1016/j.ijcard.2022.04.064

Imran, T. F., Mohebali, D., Lopez, D., Goli, R. R., DeFilippis, E. M., Truong, S., Bello, N. A., Gaziano, J. M., Djousse, L., Coglianese, E. E., Feinberg, L., Wu, W.-C., Choudhary, G., Arany, Z., Kociol, R., & Sabe, M. A. (2022). NT-proBNP and predictors of event free survival and left ventricular systolic function recovery in peripartum cardiomyopathy. International Journal of Cardiology, 357, 48–54. https://doi.org/10.1016/j.ijcard.2022.03.052

Min, J., Putt, M. E., Yang, W., Bertoni, A. G., Ding, J., Lima, J. A. C., Allison, M. A., Barr, R. G., Al-Naamani, N., Patel, R. B., Beussink-Nelson, L., Kawut, S. M., Shah, S. J., & Freed, B. H. (2022). Association of Pericardial Fat with Cardiac Structure, Function, and Mechanics: The Multi-Ethnic Study of Atherosclerosis. Journal of the American Society of Echocardiography, 35(6), 579-587.e5. https://doi.org/10.1016/j.echo.2022.01.005

Batra, J., Rosenblum, H., Cappelli, F., Zampieri, M., Olivotto, I., Griffin, J. M., Saith, S. E., Teruya, S., De Los Santos, J., Argiro, A., Burkhoff, D., Perfetto, F., & Maurer, M. S. (2022). Racial Differences in Val122Ile-Associated Transthyretin Cardiac Amyloidosis. Journal of Cardiac Failure, 28(6), 950–959. https://doi.org/10.1016/j.cardfail.2021.12.016

Obi, C. A., Mostertz, W. C., Griffin, J. M., & Judge, D. P. (2022). ATTR Epidemiology, Genetics, and Prognostic Factors. Methodist DeBakey Cardiovascular Journal, 18(2), 17–26. https://doi.org/10.14797/mdcvj.1066

Cuddy, S. A. M., Jerosch-Herold, M., Falk, R. H., Kijewski, M. F., Singh, V., Ruberg, F. L., Sanchorawala, V., Landau, H., Maurer, M. S., Yee, A. J., Bianchi, G., Di Carli, M. F., Liao, R., Kwong, R. Y., & Dorbala, S. (2022). Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy. JACC: Cardiovascular Imaging, 15(4), 594–603. https://doi.org/10.1016/j.jcmg.2021.09.032

DeFilippis, E. M., Beale, A., Martyn, T., Agarwal, A., Elkayam, U., Lam, C. S. P., & Hsich, E. (2022). Heart Failure Subtypes and Cardiomyopathies in Women. Circulation Research, 130(4), 436–454. https://doi.org/10.1161/circresaha.121.319900

Grady, K. L., Andrei, A., Elenbaas, C., Warzecha, A., Baldridge, A., Kao, A., Spertus, J. A., Pham, D., Dew, M. A., Hsich, E., Cotts, W., Hartupee, J., Pamboukian, S. V., Pagani, F. D., Petty, M., Lampert, B., Johnson, M., Murray, M., Takeda, K., … Yancy, C. (2022). Health‐Related Quality of Life in Older Patients With Advanced Heart Failure: Findings From the SUSTAIN‐IT Study. Journal of the American Heart Association, 11(4). https://doi.org/10.1161/jaha.121.024385

Farooqi, N., Metherell, L. A., Schrauwen, I., Acharya, A., Khan, Q., Nouel Saied, L. M., Ali, Y., El-Serehy, H. A., Jalil, F., & Leal, S. M. (2021). Exome Sequencing Identifies a Novel FBN1 Variant in a Pakistani Family with Marfan Syndrome That Includes Left Ventricle Diastolic Dysfunction. Genes, 12(12), 1915. https://doi.org/10.3390/genes12121915